Chemistry Wealth Management’s Intel INTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
7,439
-1,977
-21% -$200K 0.17% 82
2026
Q1
$416K Sell
9,416
-361
-4% -$16.5K 0.07% 138
2025
Q4
$361K Sell
9,777
-162
-2% -$6.12K 0.07% 144
2025
Q3
$333K Sell
9,939
-415
-4% -$10.1K 0.06% 152
2025
Q2
$232K Sell
10,354
-250
-2% -$5.18K 0.05% 176
2025
Q1
$241K Buy
+10,604
New +$232K 0.06% 158
2024
Q4
Sell
-9,750
Closed -$229K 186
2024
Q3
$229K Sell
9,750
-1,853
-16% -$46.3K 0.05% 160
2024
Q2
$359K Buy
11,603
+104
+0.9% +$3.41K 0.09% 116
2024
Q1
$508K Sell
11,499
-100
-0.9% -$4.46K 0.14% 97
2023
Q4
$583K Buy
11,599
+400
+4% +$16.2K 0.18% 84
2023
Q3
$398K Sell
11,199
-866
-7% -$30.2K 0.13% 100
2023
Q2
$403K Sell
12,065
-1,490
-11% -$46.8K 0.13% 102
2023
Q1
$443K Buy
13,555
+1,217
+10% +$34.5K 0.15% 96
2022
Q4
$326K Sell
12,338
-5,737
-32% -$159K 0.13% 105
2022
Q3
$466K Sell
18,075
-2,274
-11% -$77.5K 0.18% 85
2022
Q2
$761K Sell
20,349
-180
-0.9% -$7.79K 0.29% 59
2022
Q1
$1.02M Buy
20,529
+802
+4% +$39.8K 0.35% 49
2021
Q4
$1.02M Buy
+19,727
New +$1.01M 0.85% 30

Other funds holding INTC

Chemistry Wealth Management's INTC Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Intel (INTC) stake by 21% in Q2 2026, selling an estimated $200K and leaving 7,439 shares worth $1.04M. The position accounts for 0.17% of the portfolio, ranked #82.

Chemistry Wealth Management first reported a position in INTC in Q4 2021 and has held it in 18 quarters since. 935 funds tracked by Wall St. Rank hold INTC as of Q2 2026.

  • Chemistry Wealth Management held 7,439 shares of Intel worth $1.04M as of Q2 2026.
  • Chemistry Wealth Management sold 1,977 Intel shares in Q2 2026, an estimated $200K.
  • Intel made up 0.17% of Chemistry Wealth Management's portfolio in Q2 2026, its #82 holding.
  • Chemistry Wealth Management first reported a position in Intel in Q4 2021 and has held it in 18 quarters since.
  • 935 funds tracked by Wall St. Rank held Intel as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.